Science | Nature | Cell | View More
Natural Products
Liquiritigenin
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Liquiritigenin
Price: $30 / 20mg
CAS No.: 578-86-9
Catalog No.: CFN99156
Molecular Formula: C15H12O4
Molecular Weight: 256.25 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Source: The roots of Glycyrrhiza uralensis Fisch.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS    SDF    Manual
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $8.9 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Technical University of Denmark (Denmark)
  • Leibniz Institute of Plant Bioc... (Germany)
  • Molecular Biology Institute of ... (Spain)
  • Sri Sai Aditya Institute of Pha... (India)
  • University of Ioannina (Greece)
  • Seoul National University of Sc... (Korea)
  • Gyeongsang National University (Korea)
  • Monash University Sunway Campus (Malaysia)
  • Washington State University (USA)
  • University of Auckland (New Zealand)
  • Pennsylvania State University (USA)
  • More...
Package
Featured Products
Benzoic acid

Catalog No: CFN97121
CAS No: 65-85-0
Price: $25/20mg
Zerumbone

Catalog No: CFN91066
CAS No: 471-05-6
Price: $70/20mg
Lobetyolin

Catalog No: CFN99104
CAS No: 136085-37-5
Price: $168/20mg
Apiin

Catalog No: CFN90165
CAS No: 26544-34-3
Price: $248/20mg
Camelliaside A

Catalog No: CFN93559
CAS No: 135095-52-2
Price: $318/20mg
4-O-Feruloylquinic acid

Catalog No: CFN92392
CAS No: 2613-86-7
Price: $368/10mg
Catharanthine

Catalog No: CFN99765
CAS No: 2468-21-5
Price: $40/20mg
Tectorigenin

Catalog No: CFN99920
CAS No: 548-77-6
Price: $80/20mg
Ganoderic acid F

Catalog No: CFN92055
CAS No: 98665-15-7
Price: $318/20mg
Biatractylolide

Catalog No: CFN95205
CAS No: 182426-37-5
Price: $268/10mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Liquiritigenin, is an estrogenic compound which acts as an agonist selective for the β-subtype of the estrogen receptor, possesses anti-inflammatory, antihyperlipidemic, and antiallergic effects. Liquiritigenin can dose dependently alleviate mechanical, thermal and cold hyperalgesia, it may be potentially useful novel treatments for neuropathic pain. It exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways.
Targets: GSK-3 | TNF-α | IL Receptor | IkB | p65 | ROS | JNK | Caspase | Bcl-2/Bax | p38MAPK | ERK | MMP(e.g.TIMP) | IKK
In vitro:
Biomed Res Int. 2014;2014:965316.
Liquiritigenin induces tumor cell death through mitogen-activated protein kinase- (MPAKs-) mediated pathway in hepatocellular carcinoma cells.[Pubmed: 24738081]
Liquiritigenin (LQ), separated from Glycyrrhiza radix, possesses anti-inflammatory, antihyperlipidemic, and antiallergic effects.
METHODS AND RESULTS:
Our present study aims to investigate the antihepatocellular carcinoma effects of LQ both in cell and animal models. LQ strikingly reduced cell viability, enhanced apoptotic rate, induced lactate dehydrogenase over-release, and increased intracellular reactive oxygen species (ROS) level and caspase 3 activity in both PLC/PRL/5 and HepG2 cells. The expression of cleaved PARP, the hall-marker of apoptosis, was enhanced by LQ. LQ treatment resulted in a reduction of the expressions of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xL), and an increase of the phosphorylation of c-Jun N-terminal kinases (JNK) and P38. LQ-mediated cell viability reduction, mitochondrial dysfunction, apoptosis related protein abnormal expressions, and JNK and P38 activation were partially abolished by N-Acetyl-L-cysteine (a ROS inhibitor) pretreatment. Moreover, LQ suppressed the activation of extracellular signaling-regulated kinase (ERKs) and reduced the translocation of phosphor-ERKs from cytoplasm to nucleus. This antitumor activity was further confirmed in PLC/PRL/5-xenografted mice model. All these data indicate that the antihepatocellular carcinoma effects of LQ are related to its modulation of the activations of mitogen-activated protein kinase (MAPKs).
CONCLUSIONS:
The study provides experimental evidence supporting LQ as a potential therapeutic agent for hepatocellular carcinoma treatment.
2014 Jul 25;5(7):1432-40.
Protective effect of liquiritigenin against methylglyoxal cytotoxicity in osteoblastic MC3T3-E1 cells[Pubmed: 24789098]
Methylglyoxal (MG), a reactive dicarbonyl compound, is a metabolic byproduct of glycolysis and elevated MG levels contribute to diabetic complications. Glycation reactions of MG with amino acids can induce oxidative stress, leading to subsequent cytotoxicity. In the present study, the effect of Liquiritigenin on MG-induced cytotoxicity was investigated using osteoblastic MC3T3-E1 cells. Pretreatment of MC3T3-E1 cells with Liquiritigenin prevented the MG-induced cell death and production of protein adduct, intracellular reactive oxygen species, mitochondrial superoxide, cardiolipin peroxidation, and TNF-α in osteoblastic MC3T3-E1 cells. In addition, Liquiritigenin increased the activity of glyoxalase I inhibited by MG. These findings suggest that Liquiritigenin provides a protective action against MG-induced cell damage by reducing oxidative stress and by increasing MG detoxification. Pretreatment with Liquiritigenin prior to MG exposure reduced MG-induced mitochondrial dysfunction by preventing mitochondrial membrane potential dissipation and adenosine triphosphate loss. Additionally, the nitric oxide and PGC-1α levels were significantly increased by Liquiritigenin, suggesting that Liquiritigenin may induce mitochondrial biogenesis. Our findings indicate that Liquiritigenin might exert its therapeutic effects via enhancement of glyoxalase I activity and mitochondrial function, and anti-oxidant and anti-inflammatory activities. Taken together, Liquiritigenin has potential as a preventive agent against the development of diabetic osteopathy related to MG-induced oxidative stress in diabetes.
In vivo:
J Gastroenterol Hepatol. 2014 Oct 14.
Liquiritigenin ameliorates TNBS-induced colitis in mice.[Pubmed: 25311527]
The anti-inflammatory effects of Liquiritigenin, a major flavonoid isolated from Glycyrrhizae uralensis, have been reported in many inflammation models. However, its protective effects have not been reported in a colitis model. This study investigated the anti-inflammatory effect and mechanism of Liquiritigenin for trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice.
METHODS AND RESULTS:
Male mice imprinting control regions (ICR) were randomly divided into five groups: normal, TNBS-induced colitis, colitis treated with Liquiritigenin at low dose (10 mg/kg) and high dose (20 mg/kg), or mesalazine (10 mg/kg). TNBS colitis induction was performed except for in the normal group, and they were treated with Liquiritigenin or mesalazine except control group. The treatment effect was measured after three days treatment, by body weight, colon length, macroscopic score, histological score, levels of cytokines (tumor necrosis factor-α, interleukin [IL]-1β, IL-6, and IL-10) in colon tissue as well as the nuclear factor kappa-light-chain-enhancer pathway of activated B cells (NF-κB) activation. Mice treated with high-dose Liquiritigenin showed significant body weight gain, inhibition of colon shortening, protective effect on histological damages, and myeloperoxidase activity of colon tissue compared with the control group. Furthermore, mice treated with high-dose Liquiritigenin experienced significantly suppressed tumor necrosis factor-α, IL-1β, and IL-6 as well as enhanced IL-10 expression (all P < 0.05). High-dose Liquiritigenin treatment group showed significant decreases in TNBS-induced phosphorylation of IKKβ, p65, and IκB-α.
CONCLUSIONS:
Liquiritigenin may ameliorate TNBS-induced colitis in mice by suppressing expression of pro-inflammatory cytokines through NF-κB pathway.
Sci Rep. 2014 Jul 14;4:5676.
Liquiritigenin alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model.[Pubmed: 25022218]
This study assessed the potential antinociceptive effects of Liquiritigenin, a plant-derived compound with transient receptor potential melastatin 3 blocking activity in a rat model of persistent neuropathic pain.
METHODS AND RESULTS:
Chronic constriction injury (CCI) to the sciatic nerve was induced in male Sprague-Dawley rats to model human peripheral neuropathic pain. Liquiritigenin (1, 3, or 9 mg/kg) was administered intraperitoneally to examine the effects on mechanical, thermal, and cold hyperalgesia using the von Frey test, plantar test, and cold plate test, respectively. A rotarod test was also conducted to examine motor function. Liquiritigenin dose dependently alleviated mechanical, thermal and cold hyperalgesia. In addition, daily repeated treatment with Liquiritigenin did not demonstrate significant antinociceptive tolerance in the measures of hyperalgesia. Within the doses studied, Liquiritigenin did not significantly affect motor performance.
CONCLUSIONS:
These results suggest that Liquiritigenin may be potentially useful novel treatments for neuropathic pain.
Liquiritigenin Description
Source: The roots of Glycyrrhiza uralensis Fisch.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
4-O-Coumaroylquinic acid

Catalog No: CFN95508
CAS No: 53539-37-0
Price: $318/5mg
Aromadendrene

Catalog No: CFN95074
CAS No: 489-39-4
Price: $40/20mg
Methyl ganoderate D

Catalog No: CFN95581
CAS No: 97210-12-3
Price: $318/5mg
alpha-Costic acid

Catalog No: CFN95322
CAS No: 28399-17-9
Price: $318/5mg
Methyl nomilinate

Catalog No: CFN95576
CAS No: 77887-51-5
Price: $318/5mg
Planispine A

Catalog No: CFN95348
CAS No: 1202761-42-9
Price: $318/10mg
New compound 15

Catalog No: CFN95413
CAS No: N/A
Price: $413/5mg
2',4'-Dihydroxychalcone

Catalog No: CFN95493
CAS No: 1776-30-3
Price: $318/20mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.9024 mL 19.5122 mL 39.0244 mL 78.0488 mL 97.561 mL
5 mM 0.7805 mL 3.9024 mL 7.8049 mL 15.6098 mL 19.5122 mL
10 mM 0.3902 mL 1.9512 mL 3.9024 mL 7.8049 mL 9.7561 mL
50 mM 0.078 mL 0.3902 mL 0.7805 mL 1.561 mL 1.9512 mL
100 mM 0.039 mL 0.1951 mL 0.3902 mL 0.7805 mL 0.9756 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Animal Research:
Biol Pharm Bull. 2015;38(2):184-92.
Tacrine, an Oral Acetylcholinesterase Inhibitor, Induced Hepatic Oxidative Damage, Which Was Blocked by Liquiritigenin through GSK3-beta Inhibition.[Pubmed: 25747977]
Although the cholinesterase inhibitor tacrine has been successfully used for the treatment of Alzheimer's disease, it is known to have hepatotoxic effects. Liquiritigenin (LQ), an active flavonoid in Glycyrrhizae radix, exerts protective effects against liver damage.
METHODS AND RESULTS:
This study investigated the toxic effect of tacrine on hepatocytes and the beneficial effect of LQ on tacrine intoxication in vivo and in vitro, and the underlying mechanism involved. In hepatocyte cell lines, tacrine induced cell death and oxidative stress, as indicated by decreases in cell viability and glutathione (GSH) contents, which were blocked by pretreatment with LQ. Fluorescent activated cell sorter (FACS) analysis revealed that LQ inhibited cellular H2O2 production and mitochondrial dysfunction induced by tacrine in HepG2 cells. Furthermore, LQ promoted inhibitory phosphorylation of glycogen synthase kinase-3β (GSK3β) and prevented decreases in GSK3β phosphorylation induced by tacrine. In rats treatment with tacrine at 30 mg/kg increased hepatic damage as assessed by blood biochemistry and histopathology. Administration of LQ (10 or 30 mg/kg/d, per os (p.o.)) or the hepatoprotective drug sylimarin (100 mg/kg/d) for 3 d inhibited elevations in alanine aminotransferase, aspartate aminotransferase, and histological changes induced by tacrine.
CONCLUSIONS:
These results show that LQ efficaciously protects the rat liver against tacrine-induced liver damage, and suggest that LQ is a therapeutic candidate for ameliorating the hepatotoxic effects of tacrine.
Benzoic acid

Catalog No: CFN97121
CAS No: 65-85-0
Price: $25/20mg
Zerumbone

Catalog No: CFN91066
CAS No: 471-05-6
Price: $70/20mg
Lobetyolin

Catalog No: CFN99104
CAS No: 136085-37-5
Price: $168/20mg
Apiin

Catalog No: CFN90165
CAS No: 26544-34-3
Price: $248/20mg
Camelliaside A

Catalog No: CFN93559
CAS No: 135095-52-2
Price: $318/20mg
4-O-Feruloylquinic acid

Catalog No: CFN92392
CAS No: 2613-86-7
Price: $368/10mg
Catharanthine

Catalog No: CFN99765
CAS No: 2468-21-5
Price: $40/20mg
Tectorigenin

Catalog No: CFN99920
CAS No: 548-77-6
Price: $80/20mg
Ganoderic acid F

Catalog No: CFN92055
CAS No: 98665-15-7
Price: $318/20mg
Biatractylolide

Catalog No: CFN95205
CAS No: 182426-37-5
Price: $268/10mg
Tags: buy Liquiritigenin | Liquiritigenin supplier | purchase Liquiritigenin | Liquiritigenin cost | Liquiritigenin manufacturer | order Liquiritigenin | Liquiritigenin distributor